HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard A Flavell Selected Research

Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)

1/2023Cholinergic control of Th17 cell pathogenicity in experimental autoimmune encephalomyelitis.
1/2022CD4+ T-cell-derived IL-10 promotes CNS inflammation in mice by sustaining effector T cell survival.
1/2020NK cell receptor NKG2D enforces proinflammatory features and pathogenicity of Th1 and Th17 cells.
1/2017Long-term consumption of caffeine-free high sucrose cola beverages aggravates the pathogenesis of EAE in mice.
7/2011Control of TH17 cells occurs in the small intestine.
5/2007T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.
11/2006Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.
2/2005T cells from epicutaneously immunized mice are prone to T cell receptor revision.
12/2002Targeting autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytes.
8/2002Induction of experimental autoimmune encephalomyelitis in the absence of c-Jun N-terminal kinase 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard A Flavell Research Topics

Disease

87Inflammation (Inflammations)
02/2024 - 11/2002
80Infections
01/2023 - 06/2002
53Neoplasms (Cancer)
10/2023 - 03/2002
32Colitis
04/2024 - 02/2002
21Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2024 - 04/2006
21Autoimmune Diseases (Autoimmune Disease)
01/2021 - 12/2002
18Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2023 - 08/2002
17Virus Diseases (Viral Diseases)
01/2023 - 03/2004
13Asthma (Bronchial Asthma)
01/2022 - 01/2002
11Fibrosis (Cirrhosis)
12/2023 - 12/2002
11Ischemia
10/2023 - 11/2002
10Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2023 - 08/2002
10Carcinogenesis
10/2020 - 08/2003
9Obesity
01/2023 - 10/2007
9Pneumonia (Pneumonitis)
04/2022 - 01/2002
9Insulin Resistance
01/2022 - 03/2004
9Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2016 - 06/2003
8Arthritis (Polyarthritis)
01/2022 - 06/2002
7Lung Injury
10/2023 - 01/2003
7Melanoma (Melanoma, Malignant)
01/2023 - 05/2006
7Atherosclerosis
10/2014 - 11/2003
7Encephalitis (Encephalitis, Rasmussen)
01/2012 - 12/2004
6Hypersensitivity (Allergy)
01/2021 - 02/2002
6Bacterial Infections (Bacterial Infection)
01/2019 - 07/2002
6West Nile Fever
01/2017 - 12/2004
6Necrosis
02/2012 - 02/2003
5Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 06/2011
5Psoriasis (Pustulosis Palmaris et Plantaris)
01/2023 - 03/2011
5COVID-19
04/2022 - 01/2021
5Infarction (Infarctions)
11/2021 - 11/2002
5Disease Progression
01/2021 - 05/2005
5Alzheimer Disease (Alzheimer's Disease)
06/2008 - 12/2002
4Non-alcoholic Fatty Liver Disease
09/2023 - 02/2012
4Neuroinflammatory Diseases
01/2022 - 09/2006
4Lymphopenia (Lymphocytopenia)
01/2022 - 05/2010
4Dysbiosis
01/2021 - 02/2012
4Ulcerative Colitis
01/2021 - 03/2008
4Human Influenza (Influenza)
04/2016 - 12/2004

Drug/Important Bio-Agent (IBA)

80CytokinesIBA
12/2023 - 01/2002
43InflammasomesIBA
01/2023 - 06/2006
38Proteins (Proteins, Gene)FDA Link
04/2024 - 03/2002
29Interleukin-10 (Interleukin 10)IBA
02/2024 - 02/2006
25Transforming Growth Factor beta (TGF-beta)IBA
12/2013 - 06/2002
21Toll-Like Receptors (Toll-Like Receptor)IBA
01/2015 - 07/2002
20Interleukin-17 (Interleukin 17)IBA
07/2023 - 03/2003
19AntigensIBA
01/2023 - 12/2002
17Interleukin-18 (Interleukin 18)IBA
12/2022 - 02/2004
15Interleukin-22 (IL-22)IBA
10/2023 - 10/2007
13Phosphotransferases (Kinase)IBA
01/2021 - 06/2002
13Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
12/2013 - 09/2003
11AntibodiesIBA
12/2023 - 06/2003
11RNA (Ribonucleic Acid)IBA
10/2023 - 12/2004
11p38 Mitogen-Activated Protein KinasesIBA
10/2023 - 06/2002
11LigandsIBA
01/2023 - 05/2004
11Messenger RNA (mRNA)IBA
01/2022 - 03/2002
10Interleukin-6 (Interleukin 6)IBA
12/2023 - 02/2006
10Antiviral Agents (Antivirals)IBA
01/2022 - 12/2004
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2011 - 05/2003
9InterferonsIBA
12/2023 - 04/2009
96-methyladenineIBA
10/2023 - 08/2018
9InterleukinsIBA
10/2023 - 06/2006
9Interleukin-9 (Interleukin 9)IBA
01/2022 - 01/2002
8Insulin (Novolin)FDA Link
12/2022 - 08/2002
8AutoantigensIBA
01/2016 - 12/2002
7Caspase 3 (Caspase-3)IBA
10/2023 - 01/2003
7Glucose (Dextrose)FDA LinkGeneric
01/2022 - 11/2002
7Mitogen-Activated Protein KinasesIBA
06/2019 - 03/2003
7DNA (Deoxyribonucleic Acid)IBA
01/2017 - 03/2003
7AutoantibodiesIBA
01/2016 - 09/2006
6LipidsIBA
09/2023 - 02/2006
6Dextrans (Dextran)FDA Link
01/2023 - 12/2010
6sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2023 - 12/2010
6VaccinesIBA
01/2023 - 07/2009
6Oxygen (Dioxygen)IBA
01/2019 - 11/2002
6NLR ProteinsIBA
06/2013 - 08/2009
6Interleukin-12 (IL 12)IBA
04/2009 - 02/2004
5Transcription Factors (Transcription Factor)IBA
02/2024 - 08/2007
5CollagenIBA
12/2023 - 03/2003
5EnzymesIBA
10/2023 - 01/2022
5ChemokinesIBA
06/2021 - 01/2007
5Interleukin-23 (Interleukin 23)IBA
01/2021 - 11/2006
5Interleukin-4 (Interleukin 4)IBA
01/2021 - 01/2002
5Interleukin-13IBA
01/2016 - 01/2002
5Transforming Growth Factors (Transforming Growth Factor)IBA
07/2013 - 09/2003
5Toll-Like Receptor 3IBA
11/2012 - 05/2004
5Double-Stranded RNA (RNA, Double Stranded)IBA
11/2012 - 05/2004
5Interleukin-1 Receptor-Associated KinasesIBA
09/2012 - 09/2006
5Poly I-CIBA
02/2011 - 03/2006
5Amyloid beta-PeptidesIBA
06/2008 - 12/2002
5Transforming Growth Factor beta1 (TGF beta 1)IBA
05/2007 - 12/2002
5CaspasesIBA
06/2005 - 03/2002
4Interleukin-10 ReceptorsIBA
12/2023 - 01/2011
4Carbon MonoxideIBA
10/2023 - 01/2003
4Interferon Type IIBA
01/2023 - 04/2009
4Viral RNAIBA
04/2022 - 06/2012
4Interferon-gamma (Interferon, gamma)IBA
01/2022 - 06/2005
4Immunoglobulin E (IgE)IBA
01/2021 - 01/2009
4Protein Isoforms (Isoforms)IBA
02/2016 - 03/2002

Therapy/Procedure

25Therapeutics
01/2023 - 03/2003
13Immunotherapy
12/2023 - 05/2004